We're on a Mission.

Our pharmaceutical partners are working on therapeutics targeting the world’s most intractable diseases, and we’re supporting their efforts from the beginning of drug discovery.

Together with our team of scientists, breakthrough technologies, and in-depth analytic services, we’re revolutionizing the drug discovery process — helping our partners tackle previously incurable diseases and promoting a healthier world.

Experts in the Field, Changing the Game

Join Our Team

Recognizing the limitations posed by the standard methods of epitope mapping, and determined to offer a superior alternative to drug makers, our team of leading scientists and researchers from the University of Wisconsin Madison came together to found Immuto Scientific. Today, we’re putting to use our cutting-edge technologies to accelerate the drug discovery process and help develop new lifesaving therapeutics.

Immuto Executives

Mike Sussman, PhD

Dr. Sussman is the co-founder of Immuto Scientific and one of the inventors of Immuto’s core technology- PLIMB. Dr. Sussman is a Professor in the Dept, of Biochemistry and from 1998-2018, served as Director of the Biotechnology Center at the University of Wisconsin- Madison. He received his PhD from Michigan State University and Postdoc from Yale University.

Faraz Choudhury, PhD

CEO

Daniel Benjamin, PhD

CTO

Brad Chandler

CFO

Immuto Board Members

John D Wiley, PhD

John D. Wiley is a former faculty member and chancellor of the University of Wisconsin-Madison from 2001 to 2008. Prior to serving as chancellor, John was UW–Madison’s provost and vice chancellor for academic affairs from 1994 to 2000. In his role as the university’s chief operating officer and deputy chancellor, he worked closely with deans, faculty, academic staff and student committees in the exercise of shared governance and overall management of the institution.

He also serves on several local and commuity boards, including those for the William T. Evjue Foundation, the Greater Madison Chamber of Commerce, American Family Mutual Insurance Company, UW Hospital and Clinics Authority, the Wisconsin Alumni Research Foundation, University Research Park, Madison Symphony Orchestra, Venture Investors and BioPharmaceutical Technology Center Institute.

Brad Chandler

Brad Chandler is a Board Member and Chief Financial Officer of Immuto Scientific. Prior to Immuto, Brad was a Managing Director in the Investment Banking Division of Morgan Stanley in New York City.  Brad is also the Director of the Nicholas Center for Corporate Finance and Investment Banking at the Wisconsin School of Business.  Brad holds a JD from the University of Chicago Law School, an MBA from the University of Chicago Booth School of Business and a BA from Duke University.

Matt Kelly

Matt is a co-manager at Wisconsin Investment Partners (WIP). Matt brings four years of experience as a major project finance attorney at Milbank, Tweed, Hadley & McCloy, LLP, one of the world’s leading law firms. He graduated cum laude from American University, Washington College of Law, where he served as Senior Note & Comment Editor on the Social Policy law journal. In addition to his law degree, Matt has a B.S. in Biochemistry and History from the University of Wisconsin-Madison. Matt currently serves as board observer for Swallow Solutions, LLC and SimpleMachines, Inc., a co-board observer for Silatronix, Inc., and Madison Vaccines Inc., and serves as company secretary for Phoenix and Swallow Solutions, LLC.

Greg Keenan

Greg is a Senior Director of Ventures & Accelerator at WARF. He has a M.S.E. Management of Technology from University of Pennsylvania with more than 20 years technology commercialization experience, including leadership positions in Fortune 500, startup and small-cap public companies.

Scientific Advisors

Gopalan Raghunathan, PhD,

Biologics Discovery, Merck

Richard Burgess

Emeritus Professor Oncology, University of Wisconsin- Madison

J. Leon Shohet

Emeritus Professor Electrical Engineering, University of Wisconsin- Madison

Wasfi AlAzzam, PhD

Director, Takeda Pharmaceuticals

Immuto Careers

Scientist
Wisconsin
Full-time
Job spec
Let's Talk

We’re on
a Mission.

Our pharmaceutical partners are working on therapeutics targeting the world’s most intractable diseases, and we’re supporting their efforts from the beginning of drug discovery.

Together with our team of scientists, breakthrough technologies, and in-depth analytic services, we’re revolutionizing the drug discovery process — helping our partners tackle previously incurable diseases and promoting a healthier world.

Experts in the Field, Changing the Game

Recognizing the limitations posed by the standard methods of epitope mapping, and determined to offer a superior alternative to drug makers, our team of leading scientists and researchers from the University of Wisconsin Madison came together to found Immuto Scientific. Today, we’re putting to use our cutting-edge technologies to accelerate the drug discovery process and help develop new lifesaving therapeutics.

Let's Talk

Immuto Executives

Mike Sussman, PhD

Dr. Sussman is the co-founder of Immuto Scientific and one of the inventors of Immuto’s core technology- PLIMB. Dr. Sussman is a Professor in the Dept, of Biochemistry and from 1998-2018, served as Director of the Biotechnology Center at the University of Wisconsin- Madison. He received his PhD from Michigan State University and Postdoc from Yale University.

Faraz Choudhury, PhD

CEO

Daniel Benjamin, PhD

CTO

Brad Chandler

CFO

Immuto Board Members

John D Wiley, PhD

John D. Wiley is a former faculty member and chancellor of the University of Wisconsin-Madison from 2001 to 2008. Prior to serving as chancellor, John was UW–Madison’s provost and vice chancellor for academic affairs from 1994 to 2000. In his role as the university’s chief operating officer and deputy chancellor, he worked closely with deans, faculty, academic staff and student committees in the exercise of shared governance and overall management of the institution.
He also serves on several local and commuity boards, including those for the William T. Evjue Foundation, the Greater Madison Chamber of Commerce, American Family Mutual Insurance Company, UW Hospital and Clinics Authority, the Wisconsin Alumni Research Foundation, University Research Park, Madison Symphony Orchestra, Venture Investors and BioPharmaceutical Technology Center Institute.

Brad Chandler

John D. Wiley is a former faculty member and chancellor of the University of Wisconsin-Madison from 2001 to 2008. Prior to serving as chancellor, John was UW–Madison’s provost and vice chancellor for academic affairs from 1994 to 2000. In his role as the university’s chief operating officer and deputy chancellor, he worked closely with deans, faculty, academic staff and student committees in the exercise of shared governance and overall management of the institution.
Brad Chandler is a Board Member and Chief Financial Officer of Immuto Scientific. Prior to Immuto, Brad was a Managing Director in the Investment Banking Division of Morgan Stanley in New York City.  Brad is also the Director of the Nicholas Center for Corporate Finance and Investment Banking at the Wisconsin School of Business.  Brad holds a JD from the University of Chicago Law School, an MBA from the University of Chicago Booth School of Business and a BA from Duke University.

Matt Kelly

Matt is a co-manager at Wisconsin Investment Partners (WIP). Matt brings four years of experience as a major project finance attorney at Milbank, Tweed, Hadley & McCloy, LLP, one of the world’s leading law firms. He graduated cum laude from American University, Washington College of Law, where he served as Senior Note & Comment Editor on the Social Policy law journal. In addition to his law degree, Matt has a B.S. in Biochemistry and History from the University of Wisconsin-Madison. Matt currently serves as board observer for Swallow Solutions, LLC and SimpleMachines, Inc., a co-board observer for Silatronix, Inc., and Madison Vaccines Inc., and serves as company secretary for Phoenix and Swallow Solutions, LLC.

Scientific
Advisors

Gopalan Raghunathan, PhD,

Biologics Discovery, Merck

Richard Burgess

Emeritus Professor Oncology, University of Wisconsin- Madison

J. Leon Shohet

Emeritus Professor Electrical Engineering, University of Wisconsin- Madison

Wasfi AlAzzam, PhD

Director, Takeda Pharmaceuticals

Immuto Careers

Scientist

Wisconsin

Full-time

Job spec

Get In Touch.

Your therapeutics save lives.
We save you time and resources.

Let's Talk

© Copyright 2021 Immuto Scientific. All rights reserved.